PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1510235
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1510235
US Flow Diverters Market is valued at approximately USD 79.47 million in 2023 and is anticipated to grow with a healthy growth rate of more than 13.28% over the forecast period 2024-2032. Flow diverters are devices implanted into blood vessels to treat cerebral aneurysms, particularly large or wide-necked aneurysms. These stent shaped objects are inserted into the primary artery to reroute blood flow away from the aneurysm, promoting the formation of blood clots and restructuring of the vessel wall. Flow diverters reduce the risk of an aneurysm rupturing while still maintaining blood flow to nearby branches. The trend in the US Flow Diverters Market includes increasing adoption of next-generation flow diverter technologies supported by advancements in neurointerventional techniques and growing demand for minimally invasive treatments for cerebral aneurysms.
The US Flow Diverters Market is driven by several factors such as increasing aging population, advancements in biocompatible materials, and technological advancements in imaging modalities. Continuous improvement and adoption of biocompatible materials for flow diverters are driving the growth in US Flow Diverters Market. These materials improve the safety and efficiency of devices by minimizing the risk of adverse reactions and enhancing long-term outcomes. Innovations in materials such as nitinol alloys with improved flexibility and thrombogenic coatings contribute to improved device performance and patient outcomes. This encourages neurointerventional to adopt flow diverters for treating complex aneurysms thus expanding the market. However, regulatory challenges and the stringent approval process for medical devices can impact the market growth over the forecast period.